These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4614114

  • 1. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A, Borri P.
    Minerva Gastroenterol; 1972; 18(3):165-74. PubMed ID: 4614114
    [No Abstract] [Full Text] [Related]

  • 2. [Zolimidine. Evaluation of the symptomatic effect in patients with gastroduodenal diseases].
    Rizzi B, Giacomini F, Bandini V.
    Minerva Gastroenterol; 1975; 21(4):258-65. PubMed ID: 778658
    [No Abstract] [Full Text] [Related]

  • 3. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M.
    Clin Ter; 1971 Dec 15; 59(5):417-30. PubMed ID: 5159600
    [No Abstract] [Full Text] [Related]

  • 4. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
    Camarri E, Zaccherotti L, D'Alonzo D.
    Arzneimittelforschung; 1972 Apr 15; 22(4):768-72. PubMed ID: 5068258
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of a new synthetic preparation (zolimidine) in the treatment of gastroduodenal diseases].
    Rivero Fontán JL, Barranco Jiménez M, Gómez Parra M.
    Rev Esp Enferm Apar Dig; 1972 Jul 15; 38(1):103-26. PubMed ID: 5069487
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)].
    García Alvarez M, Ramírez Armengol JA.
    Rev Clin Esp; 1972 Aug 31; 126(4):353-6. PubMed ID: 4638610
    [No Abstract] [Full Text] [Related]

  • 7. [Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
    Corazza GR, D'Ambro A, Grimoldi D.
    Minerva Dietol Gastroenterol; 1979 Aug 31; 25(1):47-58. PubMed ID: 156316
    [No Abstract] [Full Text] [Related]

  • 8. [Results of treatment with phentonium in some gastric and duodenal diseases].
    Ramasso M, Ciancamerla G, Massaro A.
    Minerva Gastroenterol; 1972 Aug 31; 18(4):236-40. PubMed ID: 4614119
    [No Abstract] [Full Text] [Related]

  • 9. [Results obtained with Dogmagel in the treatment of gastroduodenal ulcer and gastroduodenitis].
    Sánchez García-Moreno I.
    Rev Esp Enferm Apar Dig; 1974 Dec 01; 44(7):743-6. PubMed ID: 4445556
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutical prospects of a piperonylpiperazine derivative (Pifarnine) in gastroduodenal diseases in the aged].
    Porro A, Magnani P, Battaglia A.
    Farmaco Prat; 1979 Feb 01; 34(2):85-92. PubMed ID: 378690
    [No Abstract] [Full Text] [Related]

  • 11. [Gastroduodenal diseases associated with helicobacter pylori].
    Grigor'ev PIa, Iakovenko EP.
    Klin Med (Mosk); 1998 Feb 01; 76(6):11-5. PubMed ID: 9693493
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of gastroduodenal diseases with a new drug combination].
    Maiorano G, Dell'Aera P, Vitale A, Guida V.
    Minerva Gastroenterol; 1970 Feb 01; 16(4):181-90. PubMed ID: 5516915
    [No Abstract] [Full Text] [Related]

  • 13. [Study on a new protective agent of gastro-duodenal mucous membrane].
    Sardet MB, Ruas J.
    J Med Bord; 1967 Aug 01; 144(8):1188-97. PubMed ID: 5619385
    [No Abstract] [Full Text] [Related]

  • 14. [Statistical study on the treatment of gastro-duodenal ulcer, gastritis and painful gastro-esophagic syndromes].
    Gerolami A, Deck M, Camatte R, Sarles H.
    Therapeutique; 1969 Nov 01; 45(9):907-10. PubMed ID: 4903936
    [No Abstract] [Full Text] [Related]

  • 15. Effect of zolimidine, a derivative of imidazo (1,2-a) pyridine, on the gastric mucosa of patients with gastric disorders.
    Celli L, Clementi F, Santagostino C.
    Curr Ther Res Clin Exp; 1975 Jul 01; 18(1 pt 2):105-23. PubMed ID: 809228
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical and secretory studies with a new anatacid].
    Goethals C, Vantrappen G.
    Tijdschr Gastroenterol; 1967 Jul 01; 10(1):77-84. PubMed ID: 5343052
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical use of a new preparation with anti-inflammatory, analgesic and antipyretic activity. Crossed double-blind study of cases according to a sequential plan].
    Landerghini V, Quaglia G.
    Clin Ter; 1975 Jun 30; 73(6):533-60. PubMed ID: 1139868
    [No Abstract] [Full Text] [Related]

  • 18. [Personal experience in the treatment of stomach diseases (peptic ulcer and gastroduodenitis) with a synthesis of metachlopramide and beta-glycirrhetic acid].
    Lopez-Calderon Barreda, Barado Sanchez F, Garcia Perez M.
    Rev Esp Enferm Apar Dig; 1970 Dec 01; 32(7):783-94. PubMed ID: 5503933
    [No Abstract] [Full Text] [Related]

  • 19. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C.
    Clin Ter; 1979 Mar 31; 88(6):605-19. PubMed ID: 157245
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic efficacy of trithiozine (ISF 2001) in gastroduodenal diseases].
    Barbara L, Corinaldesi R, Miglioli M, Guidoboni R, Luchetta L, Lami F, Labó G.
    Minerva Gastroenterol; 1975 Mar 31; 21(4):169-83. PubMed ID: 778657
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.